ConcertAI: ASCO 2024 study indicates multi-AI model scalability key in streamlining of clinical trial site selection process ...Middle East

CAMBRIDGE, Mass., May 30, 2024 /PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study to be presented at the ASCO Annual Meeting 2024 showing that its Digital Trial...

Hence then, the article about concertai asco 2024 study indicates multi ai model scalability key in streamlining of clinical trial site selection process was published today ( Thursday 30/05/2024 - 01:37 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ConcertAI: ASCO 2024 study indicates multi-AI model scalability key in streamlining of clinical trial site selection process )

Also on site :

• The soaring price of youth sports: $50 to try out, $3,000 to play
• Nuvei and FreedomPay Announce Partnership to Unify Enterprise Payments, Globally
• Barclays investe in Ubyx per promuovere la connettività del denaro digitale